Geopolitics, the yield curve and a Fed meeting are all landing in the same window, and each one is creating a distinct dividend setup.

You get a high-conviction defense compounder, a Texas banking franchise that has never cut, and a rate-sensitive REIT trading below net asset value.

Central banks have been accumulating gold while many Americans are asking the same question: what happens to retirement savings if the dollar keeps losing purchasing power?

A free new briefing looks at why gold has returned to the spotlight, what investors learned from the monetary changes of the 1970s, and where physical gold may fit in a long-term retirement plan.

It also explains one way eligible retirement savings can potentially be repositioned without an immediate tax hit.

Get the Free Gold Retirement Briefing and See Your Options

*Reagan Gold Group does not provide financial, legal, or tax advice. This information is for educational purposes only and should not be considered investment advice. All investments carry risk, including loss of principal. Past performance is not indicative of future results. Consult your licensed financial advisor before making investment decisions.

McKesson (NYSE: MCK) is buying Precision Medicine Group for about $2.25 billion, adding clinical research, laboratory, and commercialization services to a healthcare business already moving well beyond traditional drug distribution. 

Precision will become part of McKesson’s Oncology & Multispecialty unit, one of the company’s fastest-growing operations.

The acquisition fits a broader strategy of shedding non-core assets while directing more capital toward oncology, specialty care, and services with stronger long-term growth potential. 

Specialty Care Gets Another Major Addition

Precision works with pharmaceutical and biotechnology companies from clinical research through the launch of new medicines. Bringing those capabilities inside McKesson gives the company another way to participate in healthcare beyond simply distributing products.

Look at where McKesson has been putting its money, and you find a clear pattern. The company is steadily adding businesses that place it closer to physicians, drug developers, and specialized patient care.

Distribution Is No Longer the Whole Story

McKesson’s Oncology & Multispecialty revenue climbed 33% to $14.2 billion in its fiscal first quarter, helped by previous acquisitions and growth in specialty services. Precision adds another layer to that expanding platform. 

With several deals in the strategy, you can now see McKesson becoming a broader healthcare-services company rather than simply one of America’s largest drug distributors.

The $2.25 billion acquisition pushes that transformation another meaningful step forward.

MCK currently trades at $884 and pays a dividend of $3.76 per share, a yield of 0.43%.

Woodside Energy (NYSE: WDS) is abandoning plans to invest roughly $5 billion in clean-energy projects by 2030, marking a major strategic reversal as the company redirects attention toward its core oil, gas, and LNG operations. 

The reset goes beyond canceling a spending target.

Woodside is also reviewing its $2.35 billion Beaumont New Ammonia project in Texas and targeting another $350 million in future cost reductions, showing that projects now face a tougher test before receiving additional capital. 

Core Energy Moves Back to the Center

Woodside had spent years trying to build a larger clean-energy portfolio alongside its traditional business. Management now says several proposed projects failed to produce acceptable economics or enough customer demand. 

Follow where the capital is heading, and you get a much clearer picture of the company Woodside intends to build. Oil, natural gas, and LNG are again taking priority in major investment decisions.

A More Focused Woodside Takes Shape

The company is keeping its 2030 target for reducing direct operational emissions, but it is scaling back its broader long-term emissions ambitions as its business strategy changes.

What you are left with is a more concentrated Woodside, one prepared to put its strongest businesses ahead of diversification for its own sake.

The $5 billion reversal makes clear that future growth will be judged first by whether a project strengthens the core company and earns its place in the portfolio.

WDS currently trades at $22 and pays a dividend of $1.08 per share, a yield of 4.68%.

Capital gains taxes may quietly reduce more of your investment returns than you realize.

But the tax code includes several strategies that may help reduce that bill.

Three often-overlooked areas include investment-related expenses, cost basis adjustments, and real estate selling costs.

When structured correctly, these deductions may help minimize taxable gains.

Because the rules can be complex, many investors work with fiduciary financial advisors to plan tax-efficient strategies.

Use SmartAsset’s free tool to find vetted financial advisors serving your area.

DICK’S Sporting Goods (NYSE: DKS) is beginning a major reset of Foot Locker less than a year after completing its roughly $2.5 billion acquisition, tackling excess inventory, heavy discounting, and a product assortment that has not kept pace with changing customer demand.

The challenge now is much bigger than improving one quarter.

DICK’S bought Foot Locker to build a larger global sports retail business, and management is reshaping the chain around fresher merchandise, stronger brands, and a shopping experience that can support that ambition.

Foot Locker Needs a Merchandise Reset

Foot Locker has been carrying too much older inventory while some major footwear franchises have lost momentum. DICK’S is responding by changing the variety and highlighting products customers are actively seeking.

Walk into the turnaround from the customer side, and you quickly reach the merchandise. Better stores matter, but Foot Locker first needs shoes and brands that give shoppers a reason to return.

DICK’S Brings a Stronger Retail Playbook

DICK’S enters the turnaround with years of experience managing brand relationships, product launches, inventory, and large-format sporting goods stores. Foot Locker gives it a different customer base and a much larger international presence.

DICK’S now has an opportunity to apply what works across its existing business to hundreds of Foot Locker locations and build stronger connections with major athletic brands.

Buying Foot Locker gave DICK’S immediate scale, but the real value will depend on whether it can modernize the business without losing what made the retailer important in sneakers and athletic footwear.

DKS currently trades at $129 and pays a dividend of $5.00 per share, a yield of 3.86%.

MGE Energy (MGEE) declared a quarterly dividend increase in its August 21 8-K filing.

QCR Holdings (QCRH) lifted its quarterly dividend 50% to $0.15 per share, payable October 5 to holders of record September 18.

Carlisle Companies (CSL) raised its regular quarterly dividend from $1.10 to $1.25, marking a 50th consecutive year of increases.

Martin Marietta (MLM) bumped its quarterly cash dividend to $0.84 per share, payable September 30 to holders of record September 1.

Crown Crafts (CRWS) cut its quarterly dividend 62.5% to $0.03 per share, ending 16 consecutive years of stable payouts.

UWM Holdings (UWMC) suspended its dividend after a $451.9 million quarterly loss and a $2.05 billion cash infusion from Oaktree.

Flowers Foods (FLO) trimmed its dividend and lowered full-year guidance following weak Q2 earnings.

AI researcher Keith Kaplan says investors may be looking in the wrong places.

After investing millions into AI research, he’s identified five stocks he believes could outperform the biggest tech names as the next phase of the AI boom unfolds.

His message is simple: don’t chase yesterday’s winners.

Reveal Keith Kaplan’s 5 AI Stocks Before August 31, 2026.